#Cellvizio supports physicians across a broad range of clinical indications. Improve risk-stratification for pancreatic cysts. Increase Barrett's Esophagus detection. Help characterize lung nodules. All through real-time, in vivo cellular imaging. hubs.la/Q04BVVwh0

Thank you to the global #GI community who joined us in Barcelona! Incredible sessions from @RKiesslich, Prof. Detlef Schuppan, and Prof. Jost Langhorst sparked valuable discussions on advancing targeted care in patients who struggle with food-related symptoms. #GITwitter

Heading to Barcelona for #UEGWeek 2026? Let's connect! We'd love to discuss how @CellTolerance can support your patients struggling with chronic food-related digestive symptoms. Drop a message or comment to grab a coffee & chat during the event. Look forward to seeing you there!

Prof. Dr. med. Jost Langhorst explains the clinical turning point that led him to integrate @CellTolerance into his department. Facing patient after patient with persistent digestive distress, surface-level management was no longer enough. hubs.la/Q04BgXrm0 #GITwitter

#Lungcancer often begins as small nodules making early & accurate diagnosis crucial for improving treatment outcomes & increasing survival rates. Learn how the team at @CHRU_de_Nancy is leveraging #Cellvizio's clinical value: hubs.ly/Q04B0KDD0 #HealthyLungMonth

Early diagnosis of lung nodules enables timely surgery & avoids unnecessary procedures. For #HealthyLungMonth, learn how Cellvizio captures images from inside a lung lesion in real time, in vivo, providing the advantage of unique visibility & information: hubs.la/Q04zND-B0

Prof. Jost Langhorst, MD captures a visible, real-time change on the intestinal surface during the @CellTolerance powered by #Cellvizio test. See the complete procedure in action: hubs.la/Q04ymK9V0

Leading #GI specialists came together at Clinique Paris-Bercy to witness how @CellTolerance powered by #Cellvizio, is redefining care for patients with complex food-related symptoms. Watch Dr. Cavicchi's full interview: hubs.la/Q04yWlh50 #GITwitter

Stakes for #earlydetection have never been higher. The challenge isn't just finding visible lesions, it’s spotting flat, hidden dysplasia before it progresses. "Any patient with Barrett's is a good candidate for Cellvizio." -Kamran Ayub, MD, MRCP, FASGE hubs.la/Q04yffXm0

We’re heading to DC for the 2026 @ForegutSociety Annual Meeting! As a proud exhibitor, we’re looking forward to connecting with specialists, sharing the latest clinical data, & joining the conversations driving what’s next in foregut care. Stop by & say hello at Booth 7. #AFS2026

For millions suffering from food-related symptoms, @CellTolerance powered by #Cellvizio offers a new path to elevate daily quality of life. What does this breakthrough mean for patient care? Dr. Maryan Cavicchi (Clinique Paris-Bercy) weighs in: hubs.la/Q04y2l5x0 #GITwitter

.@ESGE_news recommends #Cellvizio for enhancing pancreatic cyst diagnosis, advancing its commercial adoption. A major step towards improving diagnostic accuracy and reducing unnecessary surgeries for patients worldwide! hubs.la/Q04xM_nW0 #GITwitter #PancreaticCysts

Live at Palais du Pharo in Marseille for the Société Française du Pancréas! Exceptional presentation by Dr. Bertrand Napoléon highlighting the latest advancements in nCLE. Stop by booth 18 to chat with our team & discuss the latest clinical findings. #GITwitter #pancreaticcysts

#Cellvizio offers unprecedented cellular-level visualization, empowering physicians to treat patients with unmatched precision. This groundbreaking technology is redefining #healthcare. Discover the transformative impact: hubs.la/Q04xvt1T0 #SeeCellsChangeLives #GITwitter

#ICYMI A landmark systematic review & meta-analysis delivers major clinical validation for #Cellvizio in upper GI cancer! hubs.la/Q04x50t20 #GITwitter

We are looking forward to the Société Francaise du Pancréas at the Palais du Pharo in Marseille. Let us know if you’ll be in attendance! We’re eager to dive into lively discussions about our latest clinical data. View program highlights here: hubs.la/Q04x1Fwx0 #GITwitter

#Cellvizio in action at @Clinica_Teknon in Barcelona! Differentiating #pancreaticcyst types is critical to patient outcomes. The team recently performed procedures where #Cellvizio made a decisive difference. Kudos for leveraging cutting-edge tech to drive real clinical impact!

With a focus on reducing unnecessary procedures & enhancing patient outcomes, #Cellvizio integrates into any healthcare system & paves the way for more precise, effective healthcare. Know the latest updates on nCLE in #pancreaticcysts: hubs.la/Q04wysFk0 @neilRsharmaMD

Landmark systematic review & meta-analysis delivers major clinical validation for #Cellvizio in upper GI cancer! Real-time cellular imaging sharpens diagnostic accuracy while cutting unnecessary biopsies—a win for physicians, payers, & patients. hubs.la/Q04vrmzG0 #GITwitter